Shopping Cart
- Remove All
Your shopping cart is currently empty
VX-984 (M9831) is an oral, selective DNA-PK inhibitor that can cross the blood-brain barrier. VX-984 inhibited the conjugation of non-homologous terminal NHEJ and acted on DSBs to break DNA double strand. VX-984 is commonly seen in glioblastoma (GBM) and non-small cell lung cancer (NSC-LC) studies.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $126 | In Stock | |
| 5 mg | $275 | In Stock | |
| 10 mg | $411 | In Stock | |
| 25 mg | $732 | In Stock | |
| 50 mg | $1,090 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $302 | In Stock |
| Description | VX-984 (M9831) is an oral, selective DNA-PK inhibitor that can cross the blood-brain barrier. VX-984 inhibited the conjugation of non-homologous terminal NHEJ and acted on DSBs to break DNA double strand. VX-984 is commonly seen in glioblastoma (GBM) and non-small cell lung cancer (NSC-LC) studies. |
| Synonyms | M9831 |
| Molecular Weight | 415.49 |
| Formula | C23H21D2N7O |
| Cas No. | 1476074-39-1 |
| Smiles | [2H]c1nc(C)nc([2H])c1-c1cc(NC[C@@H](C)c2cccc3c(ccnc23)C(=O)NC)ncn1 |
| Relative Density. | 1.31g/cm3 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 9.0 mg/mL (21.7 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.